COVID-19 and Disease-Modifying Anti-rheumatic Drugs
Kristin M. D’Silva, Zachary S. Wallace
Topics & Concepts
MedicineRituximabSulfasalazineRheumatologyCoronavirus disease 2019 (COVID-19)HydroxychloroquineInternal medicineTocilizumabRandomized controlled trialDiseasePandemicGlucocorticoidIntensive care medicineImmunologyInfectious disease (medical specialty)LymphomaUlcerative colitisCOVID-19 Clinical Research StudiesInflammasome and immune disordersSARS-CoV-2 and COVID-19 Research